Blauvelt A, Alonso-Llamazares J, Bhatia N, Draelos Z, DuBois J, Forman S, Gooderham M, Guenthner S, Hebert A, Lain E, Moore A, Papp K, Stein Gold L, Zirwas M, Kato S, Snyder S, Krupa D, Burnett P, Berk D, Chu D. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 3];7(2):s196. Available from: https://jofskin.org/33014/index.php/skin/article/view/2037